110 related articles for article (PubMed ID: 7762424)
1. Characterization of two kinds of lactotransferrin (lactoferrin) receptors on different target cells.
Spik G; Legrand D; Leveugle B; Mazurier J; Mikogami T; Montreuil J; Pierce A; Rochard E
Adv Exp Med Biol; 1994; 357():13-9. PubMed ID: 7762424
[TBL] [Abstract][Full Text] [Related]
2. Study on the binding of lactotransferrin (lactoferrin) to human PHA-activated lymphocytes and non-activated platelets. Localisation and description of the receptor-binding site.
Mazurier J; Legrand D; Leveugle B; Rochard E; Montreuil J; Spik G
Adv Exp Med Biol; 1994; 357():111-9. PubMed ID: 7762422
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mammalian receptors for lactoferrin.
Suzuki YA; Lönnerdal B
Biochem Cell Biol; 2002; 80(1):75-80. PubMed ID: 11908646
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin.
Legrand D; Mazurier J; Elass A; Rochard E; Vergoten G; Maes P; Montreuil J; Spik G
Biochemistry; 1992 Sep; 31(38):9243-51. PubMed ID: 1327110
[TBL] [Abstract][Full Text] [Related]
5. Activated human gamma delta T lymphocytes express functional lactoferrin receptors.
Mincheva-Nilsson L; Hammarström S; Hammarström ML
Scand J Immunol; 1997 Dec; 46(6):609-18. PubMed ID: 9420625
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-receptor interaction. Effect of surface exposed histidine residues.
Iyer S; Yip TT; Hutchens TW; Lonnerdal B
Adv Exp Med Biol; 1994; 357():245-52. PubMed ID: 7762439
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
Legrand D; Mazurier J; Maes P; Rochard E; Montreuil J; Spik G
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):733-8. PubMed ID: 1648350
[TBL] [Abstract][Full Text] [Related]
8. Characterization of lactotransferrin receptor in epithelial cell lines from non-malignant human breast, benign mastopathies and breast carcinomas.
Rochard E; Legrand D; Lecocq M; Hamelin R; Crepin M; Montreuil J; Spik G
Anticancer Res; 1992; 12(6B):2047-51. PubMed ID: 1338274
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive lactoferrin in resting, activated, and neoplastic lymphocytes.
Butler TW; Grossi CE; Canessa A; Pistoia V; Barton JC
Leuk Res; 1990; 14(5):441-7. PubMed ID: 2189046
[TBL] [Abstract][Full Text] [Related]
10. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography.
Mazurier J; Legrand D; Hu WL; Montreuil J; Spik G
Eur J Biochem; 1989 Feb; 179(2):481-7. PubMed ID: 2537213
[TBL] [Abstract][Full Text] [Related]
11. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
Leveugle B; Mazurier J; Legrand D; Mazurier C; Montreuil J; Spik G
Eur J Biochem; 1993 May; 213(3):1205-11. PubMed ID: 8389297
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristics.
Broxmeyer HE; Bicknell DC; Gillis S; Harris EL; Pelus LM; Sledge GW
Blood Cells; 1986; 11(3):429-46. PubMed ID: 3017479
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors.
Rochard E; Legrand D; Mazurier J; Montreuil J; Spik G
FEBS Lett; 1989 Sep; 255(1):201-4. PubMed ID: 2551729
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells.
Miyazawa K; Mantel C; Lu L; Morrison DC; Broxmeyer HE
J Immunol; 1991 Jan; 146(2):723-9. PubMed ID: 1702815
[TBL] [Abstract][Full Text] [Related]
15. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies.
Afeltra A; Caccavo D; Ferri GM; Addessi MA; De Rosa FG; Amoroso A; Bonomo L
Clin Exp Immunol; 1997 Aug; 109(2):279-85. PubMed ID: 9276523
[TBL] [Abstract][Full Text] [Related]
16. [Lactoferrin--its role in defense against infection and immunotropic properties].
Adamik B; Właszczyk A
Postepy Hig Med Dosw; 1996; 50(1):33-41. PubMed ID: 8778712
[TBL] [Abstract][Full Text] [Related]
17. Functional lactoferrin receptors on activated human lymphocytes.
Hammarström ML; Mincheva-Nilsson L; Hammarström S
Adv Exp Med Biol; 1995; 371A():47-53. PubMed ID: 8525969
[No Abstract] [Full Text] [Related]
18. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes.
Kataoka M; Tavassoli M
Exp Hematol; 1985 Sep; 13(8):806-10. PubMed ID: 2995102
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin binding to human platelets.
Maneva A; Taleva B; Manev V; Sirakov L
Int J Biochem; 1993 May; 25(5):707-12. PubMed ID: 8394253
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin receptors in normal and leukaemic human blood cells.
Birgens HS; Karle H; Hansen NE; Ostergaard Kristensen L
Scand J Haematol; 1984 Sep; 33(3):275-80. PubMed ID: 6095437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
